Profile data is unavailable for this security.
About the company
2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.
- Revenue in SEK (TTM)87.00k
- Net income in SEK-26.35m
- Incorporated2017
- Employees14.00
- Location2cureX ABc/o Mazars SET Revisionsbyra AB, Box 159LANDSKRONA 261 22SwedenSWE
- Websitehttps://www.2curex.com/